🔎 Trials Near Me

Utama › Kanser (semua jenis) › Tennessee › Memphis

Kajian klinikal Kanser (semua jenis) di Memphis, TN

31 kajian untuk Kanser (semua jenis) sedang mencari peserta di lokasi dalam dan sekitar Memphis (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Mengambil pesertaFasa 3
  • Baptist Memorial Hospital /ID# 281405, Memphis
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07365241

Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors

Mengambil pesertaSukarelawan sihat dialu-alukan
  • St. Jude Children's Research Hospital, Memphis
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06819475

The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials

Mengambil peserta
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital for Women, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi jauh
  • dan 1 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT06756607

Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)

Mengambil peserta
  • The West Clinic, PC dba West Cancer Center, Germantown · 14 mi jauh
Umur 70 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07629206

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Mengambil pesertaFasa 3
  • Baptist Memorial Hospital-Memphis, Memphis
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06119581

Project: Every Child for Younger Patients With Cancer

Mengambil pesertaKajian pemerhatian
  • Saint Jude Children's Research Hospital, Memphis
Sehingga umur 25 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT02402244

Revealing Information Genuinely & Honestly Across Time - Communication Preferences Visit

Mengambil pesertaSukarelawan sihat dialu-alukan
  • St. Jude Children's Research Hospital, Memphis
Umur 12 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT06993688

A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies

Mengambil pesertaFasa 1
  • The West Clinic, PLCC dba West Cancer Center, Germantown · 14 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT06759649

A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors

Mengambil pesertaFasa 1
  • The West Clinic, PLLC dba West Cancer Center, Germantown · 14 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jul 2026 · NCT06764771

Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

Mengambil pesertaFasa 2
  • St. Jude Children's Research Hospital, Memphis
Umur 2 hingga 25 · Semua jantina · Dikemas kini 24 Jul 2026 · NCT06458036

Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma

Mengambil peserta
  • St. Jude Children's Research Hospital, Memphis
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Jul 2026 · NCT06747910

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

Mengambil pesertaFasa 1
  • Baptist Memorial Hospital /ID# 280677, Memphis
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Jul 2026 · NCT05650632

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

Mengambil pesertaKajian pemerhatian
  • Methodist LeBonheur Healthcare, Memphis
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Jul 2026 · NCT05181826

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • The West Clinic, PLLC dba West Cancer Center, Germantown · 14 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jul 2026 · NCT05768139

Evaluation of Grief Therapy Approaches for Bereaved Parents

Mengambil peserta
  • St Jude's Children's Hospital (Data collection only), Memphis
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Jul 2026 · NCT05142605

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

Mengambil pesertaFasa 1/2
  • Baptist Medical Center, Memphis
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Jun 2026 · NCT06162221

Establishment of a Lifetime of Cohort of Adults Surviving Childhood Cancer

Mengambil pesertaKajian pemerhatian
  • St. Jude Children's Research Hospital, Memphis
Umur 5 ke atas · Semua jantina · Dikemas kini 17 Jun 2026 · NCT00760656

Childhood Cancer Survivor Study

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • St. Jude Children's Research Hospital, Memphis
Semua umur · Semua jantina · Dikemas kini 17 Jun 2026 · NCT01120353

Protocol For Collecting Data On Patients With Childhood Cancer

Mengambil pesertaKajian pemerhatian
  • St. Jude Children's Research Hospital, Memphis
Semua umur · Semua jantina · Dikemas kini 17 Jun 2026 · NCT00684580

Response to Influenza Vaccination in Pediatric Oncology Patients

Mengambil pesertaKajian pemerhatian
  • St. Jude Children's Research Hospital, Memphis
Sehingga umur 18 · Semua jantina · Dikemas kini 12 Jun 2026 · NCT05384288

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Mengambil pesertaFasa 1/2
  • Baptist Memorial Hospital Baptist Cancer Center, Memphis
Umur 12 ke atas · Semua jantina · Dikemas kini 27 Mei 2026 · NCT03093116

Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients

Mengambil pesertaFasa 1/2
  • St. Jude Children's Research Hospital, Memphis
Sehingga umur 30 · Semua jantina · Dikemas kini 19 Mei 2026 · NCT05468359

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

Mengambil pesertaFasa 1/2
  • St. Jude Children's Research Hospital, Memphis
12 Months – 30 Years · Semua jantina · Dikemas kini 19 Mei 2026 · NCT04901702

GEMINI-NSCLC: NSCLC Biomarker Study

Mengambil pesertaKajian pemerhatian
  • Baptist Cancer Center, Memphis
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Feb 2026 · NCT05236114

Caris Biorepository Research Protocol

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • West Cancer Center, Germantown · 14 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Jan 2026 · NCT01499394

Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

Mengambil pesertaFasa 2
  • St. Jude Children's Research Hospital, Memphis
Umur 2 hingga 99 · Semua jantina · Dikemas kini 14 Nov 2025 · NCT05783323

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

Mengambil pesertaKajian pemerhatian
  • St. Jude Children's Research Hospital, Memphis
Umur 0 ke atas · Semua jantina · Dikemas kini 14 Nov 2025 · NCT05024929

Childhood Cancer Predisposition Study (CCPS)

Mengambil pesertaKajian pemerhatian
  • St. Jude Children's Research Hospital, Memphis
Semua umur · Semua jantina · Dikemas kini 29 Okt 2025 · NCT04511806

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Mengambil pesertaKajian pemerhatian
  • Massive Bio SYNERGY-AI site, Memphis
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Making Healthy Habits Stick

Mengambil peserta
  • University of Tennessee Health Science Center, Memphis
Umur 19 ke atas · Wanita · Dikemas kini 1 Okt 2025 · NCT06745180

Kajian Kanser (semua jenis) di bandar lain

Kajian lain di Memphis

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.